Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F8FB9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,525
Award facts
- Contract value 100% obligated
- $12,524.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,524.82 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2 pen/mL formulation. This is a firm fixed-price, non-set-aside contract awarded on January 27, 2026, with an ultimate completion date of January 28, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora, Inc. (doing business as AmerisourceBergen). The pharmaceutical will be supplied to the place of performance in Conshohocken, PA.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Cosentyx is a specialized immunosuppressant medication used in the treatment of autoimmune conditions, reflecting the company's capability to deliver specialty pharmaceuticals critical to military medical operations.
Quick answers
Who was awarded contract SPE2DR26F8FB9?
SPE2DR26F8FB9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F8FB9 worth?
The government has obligated $12,525 on SPE2DR26F8FB9.
Is contract SPE2DR26F8FB9 an order under another contract?
Yes. SPE2DR26F8FB9 is a delivery order under SPE2DR25D3110, an indefinite delivery contract.
Was contract SPE2DR26F8FB9 competed?
The extent of competition for SPE2DR26F8FB9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award